ARENA, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.075
EU - Europa 930
AS - Asia 212
AF - Africa 2
OC - Oceania 1
Totale 2.220
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.070
RU - Federazione Russa 362
PL - Polonia 269
IT - Italia 107
IE - Irlanda 94
SE - Svezia 69
SG - Singapore 58
CN - Cina 50
HK - Hong Kong 37
JO - Giordania 36
IN - India 17
DE - Germania 13
VN - Vietnam 9
CA - Canada 5
FI - Finlandia 5
GB - Regno Unito 4
KR - Corea 3
NL - Olanda 3
CI - Costa d'Avorio 2
ES - Italia 2
NP - Nepal 2
AU - Australia 1
CH - Svizzera 1
FR - Francia 1
Totale 2.220
Salva come PNG Salva come JPEG
Città #
Warsaw 268
Santa Clara 215
Fairfield 151
Dublin 94
Ashburn 82
Chandler 74
Woodbridge 61
Houston 49
Singapore 49
Seattle 46
Cambridge 45
Wilmington 39
Florence 28
Altamura 26
Lawrence 26
Hong Kong 18
Princeton 18
Ann Arbor 17
Buffalo 17
Mumbai 15
Moscow 13
Beijing 12
Boston 12
New York 10
Shanghai 10
Bremen 7
Medford 5
Milan 5
Dong Ket 4
Falls Church 4
Los Angeles 4
San Diego 4
Hillsboro 3
Kent 3
Ottawa 3
Perugia 3
Phoenix 3
Rome 3
Villaricca 3
Abidjan 2
Andover 2
Aosta 2
Barcelona 2
Boardman 2
Bologna 2
Central 2
Dearborn 2
Helsinki 2
Incisa 2
Kathmandu 2
Laurel 2
London 2
Modena 2
Norwalk 2
Padova 2
Toronto 2
Treviso 2
Venice 2
Aachen 1
Arnsberg 1
Bern 1
Brindisi 1
Brisbane 1
Cesena 1
Chiswick 1
Dongyang 1
Esslingen am Neckar 1
Groningen 1
Guangzhou 1
Jacksonville 1
Kilburn 1
Lissone 1
Messina 1
Nantong 1
Olgiate Olona 1
Portland 1
Pune 1
Ravenna 1
Redwood City 1
San Mateo 1
Scandicci 1
Seoul 1
Shenyang 1
Villa Minozzo 1
Yubileyny 1
Totale 1.514
Salva come PNG Salva come JPEG
Nome #
Acute on chronic liver failure: From pathophysiology to clinical management. 228
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 208
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 200
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 150
A large rheumatoid nodule mimicking hepatic malignancy 142
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 129
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 119
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 99
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 91
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 83
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 79
Time-varying mHAP III is the most accurate predictor of survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 74
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 74
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 71
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 70
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter 68
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life 65
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 62
Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 54
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 54
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 47
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution? 42
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 22
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms 21
Totale 2.252
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020270 0 0 0 0 49 38 42 46 37 22 29 7
2020/2021265 18 20 5 31 11 16 14 33 20 57 27 13
2021/2022125 1 15 11 4 1 4 8 6 11 9 22 33
2022/2023417 28 72 29 18 32 70 50 36 59 2 15 6
2023/2024179 6 18 26 7 14 33 7 26 5 13 11 13
2024/2025753 60 126 78 208 281 0 0 0 0 0 0 0
Totale 2.252